T1	Drug_or_compound 26 32	STX243
T4	Pathological_formation 69 82	breast cancer
T5	Drug_or_compound 110 151	2-ethyloestradiol-3,17-O,O-bis-sulphamate
T6	Drug_or_compound 153 159	STX243
T9	Drug_or_compound 285 291	STX243
T10	Drug_or_compound 349 368	2-methoxyoestradiol
T11	Drug_or_compound 370 377	2-MeOE2
T12	Drug_or_compound 417 448	2-MeOE2-3,17-O,O-bis-sulphamate
T13	Drug_or_compound 450 456	STX140
T16	Pathological_formation 463 469	tumour
T18	Drug_or_compound 547 553	STX243
T19	Drug_or_compound 600 606	STX243
T20	Drug_or_compound 611 617	STX140
T23	Pathological_formation 658 686	MDA-MB-231 xenograft tumours
T24	Drug_or_compound 775 782	2-MeOE2
T26	Pathological_formation 792 798	tumour
T27	Drug_or_compound 830 836	STX243
T28	Pathological_formation 861 895	MCF-7 paclitaxel-resistant tumours
T33	Drug_or_compound 973 979	STX243
T34	Drug_or_compound 984 990	STX140
T37	Drug_or_compound 1138 1144	STX243
T38	Drug_or_compound 1336 1342	STX243
T1000	Organism 1201 1205	rats
T30	Drug_or_compound 867 877	paclitaxel
